Abstract:Key PointsCellular senescence is a process that is mainly designed to eliminate unwanted cells by inducing tissue remodelling.In general, cellular senescence promotes tissue remodelling through three sequential processes: a stable proliferative arrest; a secretory phenotype (SASP) that recruits immune cells and modifies the extracellular matrix; and the mobilization of nearby progenitors that repopulate the tissue. We refer to this sequence of events as the senescence–clearance–regeneration model.During normal embryonic development, cellular senescence contributes to tissue remodelling and morphogenesis by the elimination of transient structures and by regulating the relative abundance of different cell populations.Senescence is also activated upon cellular damage as a defence mechanism. In the case of oncogenic damage, senescence limits tumour progression. Following tissue damage, senescence coordinates tissue remodelling, thereby participating in multiple pathologies, including fibrotic diseases, vascular disorders, obesity, type 2 diabetes, renal diseases and sarcopenia.In these pathologies, cellular senescence usually has antagonistic roles. Initially, it functions to limit the fibrotic response (by inducing senescence in the damaged cells and in the activated fibroblasts), and it also triggers an immune response that clears the damaged cells. However, at advanced pathological stages, senescent cells are not efficiently removed but accumulate and contribute to aggravate the pathological manifestations.Both pro-senescent and antisenescent approaches can be desirable depending on the therapeutic context. Pro-senescent therapies can be useful for cancer treatment and for ongoing tissue repair processes, whereas antisenescent therapies can be beneficial to eliminate the burden of senescent cells associated with stabilized fibrotic scars that accumulate during ageing or chronic damage.Proof of principle for pro-senescent and antisenescent therapies is discussed.

Cellular senescence: Molecular mechanisms and pathogenicity

Cellular senescence: Molecular mechanisms and pathogenicity

Cellular Senescence: Mechanisms and Therapeutic Potential

Cellular senescence: the good, the bad and the unknown

Cellular Senescence and Senescent Cell*

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype

A New Pathway for Senescence Regulation

Mechanisms and Regulation of Cellular Senescence

Cellular senescence: from physiology to pathology

The emerging role of senescent cells in tissue homeostasis and pathophysiology

Physiological and pathological consequences of cellular senescence

Cellular senescence in cancer: molecular mechanisms and therapeutic targets

Cellular Senescence and Anti-Cancer Therapy.

Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs

Senescence and senolysis in cancer: The latest findings

Cellular senescence: when bad things happen to good cells

The senescence-associated secretory phenotype and its physiological and pathological implications

[Pathophysiological implications of cellular senescence and prospects for novel anti-aging drugs]

Cellular Senescence: Mechanisms, Morphology, and Mouse Models

Therapeutic strategies targeting cellular senescence for cancer and other diseases